Clinical Study

Uccc-Bn-19-01- Detecting Tumor-Derived Cell-Free Dna In Csf Of Glioblastoma Patients And Determining The Correlation To Tumor Burden And Prognosis

Posted Date: Sep 11, 2020

  • Investigator: Jonathan Forbes
  • Specialties: Cancer, Oncology
  • Type of Study: Observational/Survey

The purpose of this study is to assess the feasibility of detecting circulating tumor-derived cell-free DNA (ctDNA) in CSF extracted from glioblastoma patients at pre-specified clinical time points either during surgical resection or via lumbar puncture.


To Be Eligible: Must Have Mri Imaging Highly Suggestive Of A Resectable Glioblastoma Within 60 Days, History Of Lumbar Fusion At The L2 To L4 Levels, No Use Of Anti-Coagulants, No Other Malignancy Requiring Chemo Within 5 Years, No Bmi>40


Brain Cancer, Glioblastoma

For More Information:

Uc Cancer Center

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.